Trial intelligence / Profile preview

Intravenous lidocaine versus saline for lung protection in surgical patients at intermediate to high risk of postoperative pulmonary complications

ChiCTR1900021677Phase 4Recruiting

Sponsor
The Affiliated Hospital of Xuzhou Medical University
Start
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of lidocaine and saline in postoperative respiratory complications (PRC) and not applicable; "lung injury" is not a specific disease (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: CC16 protein. Started Jun 2019; status: recruiting.

02

Drugs

lidocainesaline
03

Conditions

postoperative respiratory complications (PRC)not applicable; "lung injury" is not a specific disease

Beyond the preview

Go deeper on ChiCTR1900021677.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900021677.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call